BioSpace News Archive

Cogent Biosciences, Inc. today announced Andrew Robbins , Chief Executive Officer and President will participate in a fireside chat and one-on-one investor meetings during the Piper Sandler 33rd Annual Conference.

Teal Bio, Inc. today announced it has raised a $2.45 million Series A financing led by Caligan Partners LP.

EQRx today announced a strategic collaboration agreement with Abdul Latif Jameel Health, part of international diversified family business Abdul Latif Jameel.

Monte Rosa Therapeutics, Inc. today announced members of its management team will be participating in the Piper Sandler 33rd Annual Virtual Healthcare Conference from Nov. 30-Dec. 2, 2021.

Elucida Oncology announced today the appointment of Ian Somaiya as Chief Financial Officer and Chief Business Officer.

Mirati Therapeutics, Inc. announced a non-exclusive clinical collaboration agreement to evaluate the combination of Mirati’s investigational KRASG12C inhibitor adagrasib with Verastem Oncology’s investigational RAF/MEK inhibitor VS-6766 in KRASG12C-mutant non-small cell lung cancer.

Provention Bio, Inc. today provided an update on its ongoing efforts to address U.S. Food and Drug Administration (FDA) considerations cited in the Complete Response Letter (CRL) issued to the Company by the FDA on July 2, 2021.

StageZero Life Sciences, Ltd., a vertically integrated healthcare company devoted to improving the early detection and management of cancer and other chronic diseases through leading-edge molecular diagnostics and clinical interventions, announced that people throughout the Greater Toronto Area can now access the company’s multi-cancer blood test ARISTOTLE®.

Alterity Therapeutics today announced that David Stamler , M.D., Chief Executive Officer will participate in two upcoming virtual investor events.

Antares Pharma, Inc. (NASDAQ: ATRS) (the “Company”), a specialty pharmaceutical company, today announced that Robert F. Apple, President and Chief Executive Officer, is scheduled to virtually present and host investor meetings at the Piper Sandler 33rd Annual Virtual Healthcare Conference being held on November 29-December 2, 2021.